02-Dec-2008 - A report has predicted that contract mammalian cell culture manufacturers are likely to struggle to cope with increased demand in coming years.
02-Dec-2008 - WuXi PharmaTech is to discontinue its US biologics manufacturing operations as it attempts to cut costs, with 100 employees due to lose their jobs.
01-Dec-2008 - Postponement of this year’s CPhI and P-MEC India events for “security reasons” may be only the first impact of last week’s Mumbai terror attacks on the country’s outsourcing industry, according to PwC’s life sciences head Sujay Shetty.
01-Dec-2008 - Althea Technologies has signed a contract manufacturing deal, under which it will produce Bio-Path’s lead novel therapeutic drug for upcoming clinical trials.
27-Nov-2008 - Metrics’ new potent and cytotoxic drug development facility was the subject of a press conference at this year’s AAPS, where the company explained how the plant “raised the industry bar”.
25-Nov-2008 - Contract manufacturer Akron will provide an ophthalmic drug to an undisclosed healthcare company as part of a five year supply agreement.
25-Nov-2008 - Isogen will start operations in January at a new contract facility in Delaware that will provide small-scale sterile filling services to the pharmaceutical industry.
24-Nov-2008 - Patheon has signed a slew of agreements to boost its portfolio of contract drug development and manufacturing services, forging new alliances with Omnicare, Depomed, Senopsys and Solvias.
24-Nov-2008 - Canada’s Orbus Pharma has decided to exit the contract manufacturing business, saying that the division “posed a distraction to the core business and generated low or negative margins.”
19-Nov-2008 - CiVentiChem president Bhaskar Venepalli says that the CiVentiAnalytical unit, the firm’s new state of the art GLP/cGMP accredited laboratory in Cary, North Carolina, will help customers find novel method development solutions for API production.
19-Nov-2008 - Contract research group Recipharm has leased AstraZeneca Biotech Laboratory (ABL) in Sodertalje, Sweden, bolting on recombinant protein and monoclonal antibody development capabilities to its offering.
13-Nov-2008 - US company Irvine Pharmaceutical Services is gearing up to launch a new subsidiary company to provide fill-and-finish services for biopharmaceutical companies.
10-Nov-2008 - Patheon’s European HQ is up and running to help manage the firm’s growing European operations, specifically its development and commercial service offerings provided by units in France, Italy and the UK.
10-Nov-2008 - Cambrex joined a number of its peers in the contract services sector by reporting pressure on third quarter sales and earnings, providing further evidence that outsourcing companies are not immune to the economic downturn.
06-Nov-2008 - Barrack Obama’s election as US president has been roundly welcomed by India’s generics sector, despite his somewhat contradictory desire to reduce the level of outsourcing but not "shy away" from globalisation.
06-Nov-2008 - Contract manufacturing organisation (CMO) Metrics has completed an $18m expansion of its facility in Greenville, North Carolina, adding at least 50 jobs.
30-Oct-2008 - SAFC's Mike Harris sets out the firm's role in the expanding high-potency active pharmaceutical ingredient (HPAPI) industry.
30-Oct-2008 - The US Food and Drug Administration (FDA) has issued a warning letter to Pharmalucence for alleged deviations from current good manufacturing practices (cGMP).
30-Oct-2008 - Jubilant Organosys, India's largest custom research and manufacturing services (CRAMS) provider, has reorganised its business in North America in the wake of its recent acquisitions of HollisterStier Laboratories and Draxis Specialty Pharmaceuticals.
28-Oct-2008 - Avid Bioservices is to manufacture clinical-grade material for the trials of Catalyst Biosciences’ candidate CB 813.
27-Oct-2008 - Irish drugmaker Elan has shelved plans to sell its contracting arm EDT in favour of improving the division’s profitability, despite receiving what it describes as “considerable interest” in the unit.
27-Oct-2008 - David Hipkiss explains the benefits for pharmaceutical manufacturers of using Prosonix’ sonocrystallisation technology.
23-Oct-2008 - The pharmaceutical industry must adapt its processes and strategies to cope with a new, tougher operating environment, according to Stefan Borgas, CEO of Lonza.
21-Oct-2008 - The pharmaceutical industry sometimes seems besieged from all sides at present, and that has implications for contract manufacturers, according to Stefan Borgas, CEO of Lonza, at a recent meeting of the European Fine Chemicals Group (EFCG) in Frankfurt.
19-Oct-2008 - German contract services firm InfraServ Knapsack has added three new capabilities in its analytical division aimed at servicing Good Manufacturing Practice (GMP) production.